4//SEC Filing
Jenkins John Kenneth 4
Accession 0001209191-22-030445
CIK 0001595097other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 2:36 PM ET
Size
5.5 KB
Accession
0001209191-22-030445
Insider Transaction Report
Form 4
Jenkins John Kenneth
Director
Transactions
- Award
Stock Option(right to buy)
2022-05-18+79,600→ 79,600 totalExercise: $0.33Exp: 2032-05-18→ Common Stock (79,600 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001742557
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 2:36 PM ET
- Size
- 5.5 KB